BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32065219)

  • 1. miR-492 promotes chemoresistance to CDDP and metastasis by targeting inhibiting DNMT3B and induces stemness in gastric cancer.
    Wu S; Xie J; Shi H; Wang ZW
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32065219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-98-5p inhibits gastric cancer cell stemness and chemoresistance by targeting branched-chain aminotransferases 1.
    Zhan P; Shu X; Chen M; Sun L; Yu L; Liu J; Sun L; Yang Z; Ran Y
    Life Sci; 2021 Jul; 276():119405. PubMed ID: 33798550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway.
    Zhang JX; Xu Y; Gao Y; Chen C; Zheng ZS; Yun M; Weng HW; Xie D; Ye S
    Mol Cancer; 2017 Jan; 16(1):18. PubMed ID: 28114937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
    Zhou J; Chen Q
    FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
    Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
    Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
    Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
    Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-345 inhibits migration and stem-like cell phenotype in gastric cancer via inactivation of Rac1 by targeting EPS8.
    Zhang J; Wang C; Yan S; Yang Y; Zhang X; Guo W
    Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):259-267. PubMed ID: 32147678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-876-3p regulates cisplatin resistance and stem cell-like properties of gastric cancer cells by targeting TMED3.
    Peng C; Huang K; Liu G; Li Y; Yu C
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1711-1719. PubMed ID: 30843262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal MiR-500a-3p promotes cisplatin resistance and stemness via negatively regulating FBXW7 in gastric cancer.
    Lin H; Zhang L; Zhang C; Liu P
    J Cell Mol Med; 2020 Aug; 24(16):8930-8941. PubMed ID: 32588541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.
    Wang M; Zhang R; Zhang S; Xu R; Yang Q
    Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-17 inhibition overcomes chemoresistance and suppresses epithelial-mesenchymal transition through a DEDD-dependent mechanism in gastric cancer.
    Wu DM; Hong XW; Wang LL; Cui XF; Lu J; Chen GQ; Zheng YL
    Int J Biochem Cell Biol; 2018 Sep; 102():59-70. PubMed ID: 29953965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
    Zheng H; Wang JJ; Yang XR; Yu YL
    World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
    Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-103 Promotes Proliferation and Metastasis by Targeting KLF4 in Gastric Cancer.
    Zheng J; Liu Y; Qiao Y; Zhang L; Lu S
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28445396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail.
    Zuo QF; Cao LY; Yu T; Gong L; Wang LN; Zhao YL; Xiao B; Zou QM
    Cell Death Dis; 2015 Nov; 6(11):e2000. PubMed ID: 26610210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance.
    Wu QN; Liao YF; Lu YX; Wang Y; Lu JH; Zeng ZL; Huang QT; Sheng H; Yun JP; Xie D; Ju HQ; Xu RH
    Cancer Lett; 2018 Jan; 412():243-255. PubMed ID: 29050982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression.
    Li B; Wang W; Li Z; Chen Z; Zhi X; Xu J; Li Q; Wang L; Huang X; Wang L; Wei S; Sun G; Zhang X; He Z; Zhang L; Zhang D; Xu H; El-Rifai W; Xu Z
    Cancer Lett; 2017 Dec; 410():212-227. PubMed ID: 28965855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.
    Wang J; Xue X; Hong H; Qin M; Zhou J; Sun Q; Liang H; Gao L
    Oncotarget; 2017 Jan; 8(1):574-582. PubMed ID: 27880941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.